Page last updated: 2024-11-06

mlv 6976

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

MLV 6976: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID65882
CHEMBL ID2104917
SCHEMBL ID333881
MeSH IDM0146337

Synonyms (20)

Synonym
ipenoxazone
mlv-6976
nc-1200
(+)-(4s,5r)-3-(3-(hexahydro-1h-azepin-1-yl)propyl)-4-isobutyl-5-phenyl-2-oxazolidinone
nc 1200
2-oxazolidinone, 3-(3-(hexahydro-1h-azepin-1-yl)propyl)-4-(2-methylpropyl)-5-phenyl-, (4s-cis)-
ipenoxazone [inn]
mlv 6976
(4s,5r)-3-[3-(azepan-1-yl)propyl]-4-(2-methylpropyl)-5-phenyl-1,3-oxazolidin-2-one
unii-839f26evaq
104454-71-9
839f26evaq ,
CHEMBL2104917
SCHEMBL333881
CS-0018155
HY-100159
(4s,5r)-3-(3-(azepan-1-yl)propyl)-4-isobutyl-5-phenyloxazolidin-2-one
Q27269418
DTXSID601318288
AKOS040741885
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (10)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (60.00)18.7374
1990's2 (20.00)18.2507
2000's2 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (10.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]